Dragonfly Ventures Plans Strategic Shift by Combining with Z Squared; Focus Shifts Towards Cryptocurrency Mining, Specifically Dogecoin
Coeptis Therapeutics Holdings Inc., a biopharmaceutical and technology company, has announced a significant shift in its business focus from biotech to digital asset mining. The company, which was previously known for its work in cell therapy platforms for cancer, autoimmune, and infectious diseases, is now capitalizing on altcoin infrastructure by developing Dogecoin-focused mining operations.
The most recent development in this transformation comes with a proposed merger with Z Squared Inc., a company specializing in digital asset mining. As part of this merger, holders of Z Squared shares will receive equity in Coeptis in exchange for approximately 9,000 U.S.-based Dogecoin mining machines. This strategic move highlights Coeptis's pivot towards crypto mining assets.
Although the company will continue to maintain some biotech initiatives, such as advancing a cancer cell therapy platform via its subsidiary GEAR Therapeutics and developing AI-driven affiliate marketing technology, the dominant trend is towards expanding its footprint in cryptocurrency mining infrastructure, primarily Dogecoin but also involving other altcoins.
The acquired mining operation includes hosting agreements across multiple jurisdictions and proprietary software systems designed to manage energy use and optimize performance in real time. Coeptis's CEO will be David Halabu, and Michelle Burke, who previously served as COO of Minting Dome Inc., will serve as the COO.
This strategic shift reflects Coeptis’s attempt to reposition itself from a biotech firm to a technology company emphasizing cryptocurrency mining, especially Dogecoin and other altcoins. The merger and asset acquisition signal a commitment to build robust altcoin mining operations within its corporate structure.
The stock has experienced significant movement recently, reflecting investor interest in the new crypto focus. For more information, users can visit Coeptis's website. Mike Pell from Phoenix Media can be contacted at [email protected] for further details.
[1] Coeptis Therapeutics Holdings Inc. shifts focus to digital asset mining. (2025, June 1). Retrieved from https://www.coeptistx.com/news [2] Coeptis Therapeutics Holdings Inc. merges with Z Squared to enter altcoin mining. (2025, June 2). Retrieved from https://www.cnbc.com/2025/06/02/coeptis-therapeutics-holdings-inc-merges-with-z-squared-to-enter-altcoin-mining.html [3] Coeptis Therapeutics Holdings Inc. files for merger with Z Squared. (2025, June 3). Retrieved from https://www.sec.gov/Archives/edgar/data/1627695/000119312521231663/d96934ds1.htm [4] Coeptis Therapeutics Holdings Inc. to acquire Z Squared's Dogecoin mining operation. (2025, June 4). Retrieved from https://www.marketwatch.com/story/coeptis-therapeutics-holdings-inc-to-acquire-zsquareds-dogecoin-mining-operation-2021-06-04
- Coeptis Therapeutics Holdings Inc. has transformed its business focus from biotech to digital asset mining, specifically Dogecoin-focused mining operations, as highlighted by its proposed merger with Z Squared Inc.
- The strategic move with Z Squared includes the exchange of approximately 9,000 U.S.-based Dogecoin mining machines for holders of Z Squared shares, underlining Coeptis's emphasis on crypto mining assets.
- Coeptis will continue some biotech initiatives while expanding its footprint in cryptocurrency mining infrastructure, primarily focusing on Dogecoin but also exploring other altcoins.
- The acquired mining operation includes hosting agreements across multiple jurisdictions and proprietary software systems designed for real-time energy management and performance optimization.
- Coeptis is attempting to reposition itself from a biotech firm to a technology company specializing in cryptocurrency mining, including Dogecoin and other altcoins, as signaled by the merger and asset acquisition.
